Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

被引:0
作者
Dolores Siedlecki-Wullich
Judit Català-Solsona
Cristina Fábregas
Isabel Hernández
Jordi Clarimon
Alberto Lleó
Merce Boada
Carlos A. Saura
José Rodríguez-Álvarez
Alfredo J. Miñano-Molina
机构
[1] Universitat Autònoma de Barcelona,Institut de Neurociències and Dpt. Bioquímica i Biología Molecular
[2] Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED),Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades
[3] Universitat Internacional de Catalunya,Memory Unit, Department of Neurology
[4] Institut d’Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau,Dominick P. Purpura Department of Neuroscience
[5] Universitat Autònoma de Barcelona,undefined
[6] Albert Einstein College of Medicine,undefined
来源
Alzheimer's Research & Therapy | / 11卷
关键词
Alzheimer’s disease; Mild cognitive impairment; Synapses; miRNAs; Plasma; Human; Biomarker; Frontotemporal dementia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 300 条
[1]  
Polanco JC(2018)Amyloid-β and tau complexity-towards improved biomarkers and targeted therapies Nat Rev Neurol 14 22-39
[2]  
Li C(2018)Trial of solanezumab for mild dementia due to Alzheimer’s disease N Engl J Med 378 321-330
[3]  
Bodea LG(2018)Randomized trial of Verubecestat for mild-to-moderate Alzheimer’s disease N Engl J Med 378 1691-1703
[4]  
Martinez-Marmol R(2015)Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases Nat Rev Neurol 11 41-55
[5]  
Meunier FA(2015)Amyloid biomarkers in Alzheimer’s disease Trends Pharmacol Sci 36 297-309
[6]  
Götz J(2015)Tau in bliofluids - relation to pathology, imaging and clinical features Neuropathol Appl Neurobiol 43 194-199
[7]  
Honig LS(2013)Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 207-216
[8]  
Vellas B(2018)Biomarkers for Alzheimer disease: classical and novel candidate’s review Neuroscience 370 181-190
[9]  
Woodward M(2017)Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers Lancet Neurol 16 661-676
[10]  
Boada M(2017)Synaptic impairment in Alzheimer’s disease: a dysregulated symphony Trends Neurosci 40 347-357